New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

Transfusion

Volumn 38, Issue 1, 1998, Pages 56-59

  Jongerius, J M ^a   Wester, M ^a   Cuypers, H T M ^b   Van Oostendorp, W R ^c   Lelie, P N ^b   Van Der Poel, C L ^d   Van Leeuwen, E F ^c  

^a CENTRAL LABORATORY   (Netherlands)

^b Viral Diagnostic Laboratory

^c NONE

^d Red Cross Blood Bank

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD DONOR; CASE REPORT; DNA SEQUENCE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; RADIOIMMUNOASSAY; VIRUS MUTATION;

EID: 0031936857     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38198141499.x     Document Type: Article

References (16)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
2. Jagodzinski L, Kraus F, Garrett P, et al. Detection of hepatitis B viral sequences in early HBV infection. Transfusion 1994;34(Suppl):37S.
3. McMahon BJ, Bender TR, Berquist KR, et al. Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus. J Clin Microbiol 1981;14:130-4.
4. Bréchot C, Degos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-6.
5. Carman WF. Vaccine-associated mutants of hepatitis B virus. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease: proceedings of the International Symposium on Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994:243-7.
6. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
7. Roberts P. Virus safety of plasma products. Med Virol 1996;6:25-38.
8. Koziol DE, Holland PV, Ailing DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-95.
9. Blajchman MA, Bull SB, Feinman SV. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 1995;345:21-5.
10. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
11. NIH consensus statement on infectious disease testing for blood transfusion. Bethesda, MD: National Institutes of Health, 1995.
12. Liang TJ, Isselbacher KJ, Wands JR. Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest 1989;84:1367-71.
13. Norder H, Hammas B, Lee SD, et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993;74:1341-8.
14. Carman WF, Korula J, Wallace L, et al. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-7.
15. Waters JA, Kennedy M, Voet P, et al. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 1992;90:2543-7.
16. Rogers PM, Saldanha J, Allain JP. Report of EPFA/NIBSC workshop "nucleic acid amplification tests (NAT) for the detection of blood borne viruses" held on 31 October 1996 in Amsterdam, the Netherlands. Vox Sang 1997;72:199-206.